While C83 does not inhibit infection, blocking C99 degradation using ubiquitin-site mutants or preventing its further processing into toxic β-amyloids using a γ-secretase inhibitor impairs Gag entry into CD63-positive MVBs and suppresses the release of infectious viral particles. Here, CD63 is linked to infection.